- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有59家主力机构披露2026-06-30报告期持股数据，持仓量总计3.03亿股，占流通A股30.40%
- 波段诊断：
-
技术面诊股
诊断结果：5.3技术面打败了70%的股票
技术面评分前10的股票
近期的平均成本为5.45元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为5.45元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.45","date":1793261075,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2026.10.30","stock":"-0.55","trade":null,"ind":"-2.73"},{"date":"2026.10.29","stock":"-1.45","trade":null,"ind":"-2.92"},{"date":"2026.10.28","stock":"2.03","trade":null,"ind":"2.02"},{"date":"2026.10.27","stock":"-5.91","trade":null,"ind":"-2.50"},{"date":"2026.10.26","stock":"1.23","trade":null,"ind":"-1.19"},{"date":"2026.10.23","stock":"-2.07","trade":null,"ind":"2.79"},{"date":"2026.10.22","stock":"-4.76","trade":null,"ind":"-2.96"},{"date":"2026.10.21","stock":"-0.98","trade":null,"ind":"-0.82"},{"date":"2026.10.20","stock":"-2.23","trade":null,"ind":"-0.14"},{"date":"2026.10.19","stock":"-1.72","trade":null,"ind":"0.13"},{"date":"2026.10.16","stock":"-1.69","trade":null,"ind":"-0.12"},{"date":"2026.10.15","stock":"0.00","trade":null,"ind":"-2.43"},{"date":"2026.10.14","stock":"-1.06","trade":null,"ind":"-1.97"},{"date":"2026.10.13","stock":"1.86","trade":null,"ind":"-0.25"},{"date":"2026.10.12","stock":"-4.86","trade":null,"ind":"-2.03"},{"date":"2026.10.09","stock":"3.19","trade":null,"ind":"0.17"},{"date":"2026.10.08","stock":"4.11","trade":null,"ind":"-2.07"},{"date":"2026.09.30","stock":"3.61","trade":null,"ind":"-0.11"},{"date":"2026.09.29","stock":"0.16","trade":null,"ind":"0.34"},{"date":"2026.09.28","stock":"2.35","trade":null,"ind":"-3.44"},{"date":"2026.09.24","stock":"1.54","trade":null,"ind":"-2.34"}]
蓝帆医疗,深证成指,医疗器械指数
压力支撑
该股压力位为5.43元，支撑位为5.28元。
[{"text":"\u538b\u529b\u4f4d","value":"5.43","date":1793289600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.28","date":1793289600,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了40%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体无进出。
更新时间：10月30日 20:30
| 机构今日流向(万元) | -389.04 | 机构5日流向(万元) | 107.22 |
| 机构10日流向(万元) | 3153.14 | 机构20日流向(万元) | 313.22 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加1357.39万股，其中基金净增仓7家，主力净增仓21家，有一定的中长期投资价值。
截止2026-06-30，共59家主力机构（一般法人5家，基金54家），持仓量总计30328.92万股，占流通A股30.40%
其中，基金持仓与2025-12-31相比：
增仓：12家 ，增持 137.78万股
减仓：5家 ，减持 7.28万股
新出现在主力名单中：38家 ，持有2093.72万股
从主力名单中消失：17家 ，原持有2301.64万股
其中，基金持仓与2025-12-31相比：
增仓：12家 ，增持 137.78万股
减仓：5家 ，减持 7.28万股
新出现在主力名单中：38家 ，持有2093.72万股
从主力名单中消失：17家 ，原持有2301.64万股
消息面诊股
诊断结果：5.7消息面打败了18%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 从规模扩张转向价值创造-医疗器械行业发展趋势展望
2026-10-29 - 蓝帆医疗：北京蓝帆柏盛医疗科技股份有限公司是公司心
2026-10-28 - 蓝帆医疗最新股东户数环比下降5.64% 筹码趋向集
2026-10-27 - 蓝帆医疗（截止2026年10月20日）股东人数为6
2026-10-27 - 蓝帆医疗：环比变动主要为二季度行业价格跳涨带来大幅
2026-10-27 - 蓝帆医疗：10月26日获融资买入789.81万元
2026-10-27 - 多家药企净利润增幅超100%，增速快于营收
2026-10-26 - 大批医疗器械企业前三季度业绩增长！有企业净利高增超
2026-10-26 - 蓝帆医疗：两大主业连续三季度盈利，经营现金持续回流
2026-10-26 - 三季报速递：五家药企营利双增且净利翻倍，医药细分赛
2026-10-26
消息列表
| 一般消息 | 募资投向 | 公司出售资产 | 2026-09-24 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-09-24 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-09-01 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-25 |
| 一般消息 | 高管变动 | 股权转让带来的股权结构、管理架构统... | 2026-08-18 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-08-18 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-07-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-06 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-23 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-29 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-03-13 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-13 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-13 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-01-31 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-13 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了59%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.10.30","price":"-2.73","value":null},{"date":"2026.10.29","price":"-2.92","value":null},{"date":"2026.10.28","price":"2.02","value":null},{"date":"2026.10.27","price":"-2.50","value":null},{"date":"2026.10.26","price":"-1.19","value":null},{"date":"2026.10.23","price":"2.79","value":null},{"date":"2026.10.22","price":"-2.96","value":null},{"date":"2026.10.21","price":"-0.82","value":null},{"date":"2026.10.20","price":"-0.14","value":null},{"date":"2026.10.19","price":"0.13","value":null},{"date":"2026.10.16","price":"-0.12","value":null},{"date":"2026.10.15","price":"-2.43","value":null},{"date":"2026.10.14","price":"-1.97","value":null},{"date":"2026.10.13","price":"-0.25","value":null},{"date":"2026.10.12","price":"-2.03","value":null},{"date":"2026.10.09","price":"0.17","value":null},{"date":"2026.10.08","price":"-2.07","value":null},{"date":"2026.09.30","price":"-0.11","value":null},{"date":"2026.09.29","price":"0.34","value":null},{"date":"2026.09.28","price":"-3.44","value":null},{"date":"2026.09.24","price":"-2.34","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 新产业 | 29.62% | 9.20% | 6.1分 |
| 2 | 健帆生物 | 18.25% | 15.77% | 6.0分 |
| 3 | 迈瑞医疗 | 18.13% | 2.51% | 6.3分 |
| 4 | 惠泰医疗 | 15.23% | 1.49% | 6.4分 |
| 5 | 安图生物 | 13.46% | 8.93% | 6.2分 |
| 6 | 联影医疗 | 12.29% | 2.51% | 6.3分 |
| 8 | 三诺生物 | 11.52% | 0.00% | 5.3分 |
| 10 | 山外山 | 8.67% | 0.68% | 6.1分 |
| 12 | 阳普医疗 | 7.34% | 16.03% | 5.0分 |
| 14 | - | 6.58% | 9.21% | 分 |
| 16 | 鱼跃医疗 | 5.27% | 1.68% | 5.6分 |
| 18 | 戴维医疗 | 4.59% | -8.13% | 5.3分 |
| 20 | 三鑫医疗 | 3.10% | 0.22% | 5.8分 |
| 22 | 心脉医疗 | 2.58% | -0.23% | 5.6分 |
| 24 | ST凯利 | 2.08% | -4.93% | 5.4分 |
| 26 | 佰仁医疗 | 1.77% | 0.49% | 5.9分 |
| 28 | - | 0.22% | 3.00% | 分 |
| 30 | 利德曼 | -0.67% | 6.69% | 4.8分 |
| 32 | 天智航 | -1.83% | -3.91% | 5.3分 |
| 34 | 威高骨科 | -2.37% | -4.71% | 4.7分 |
| 36 | 迈普医学 | -2.52% | 1.32% | 4.8分 |
| 38 | 爱朋医疗 | -2.65% | 1.18% | 4.1分 |
| 40 | 维力医疗 | -3.43% | -0.09% | 4.9分 |
| 42 | 微电生理 | -3.54% | -5.12% | 5.9分 |
| 44 | 楚天科技 | -3.86% | 7.58% | 4.8分 |
| 46 | 万东医疗 | -3.99% | -6.05% | 4.3分 |
| 48 | - | -4.67% | 1.31% | 分 |
| 50 | 健尔康 | -5.10% | -3.08% | 4.6分 |
| 52 | ST迪瑞 | -5.53% | -9.02% | 4.6分 |
| 54 | 可孚医疗 | -5.61% | -6.73% | 4.9分 |
| 56 | 正川股份 | -6.65% | -6.32% | 5.5分 |
| 58 | *ST明德 | -6.82% | -1.25% | 3.5分 |
| 60 | 美康生物 | -8.13% | 2.93% | 4.8分 |
| 62 | 艾德生物 | -8.27% | -2.30% | 4.9分 |
| 64 | 达安基因 | -8.64% | -3.54% | 4.4分 |
| 66 | 九安医疗 | -8.82% | 4.11% | 4.9分 |
| 68 | 蓝帆医疗 | -9.08% | -4.75% | 5.2分 |
| 70 | 健信超导 | -9.28% | 1.63% | 5.0分 |
| 72 | 澳华内镜 | -9.83% | -7.50% | 5.5分 |
| 74 | 春立医疗 | -10.27% | -1.78% | 4.6分 |
| 76 | 东方生物 | -10.95% | -5.16% | 3.7分 |
| 78 | 黄山胶囊 | -11.14% | -5.38% | 3.8分 |
| 80 | 国发股份 | -11.79% | -1.18% | 3.6分 |
| 82 | 博拓生物 | -11.86% | -1.61% | 4.8分 |
| 84 | 超研股份 | -12.05% | -5.32% | 4.2分 |
| 86 | 英科医疗 | -12.33% | -2.09% | 5.0分 |
| 88 | - | -12.52% | -7.63% | 分 |
| 90 | 万泰生物 | -12.62% | -9.93% | 4.1分 |
| 92 | 洁特生物 | -12.76% | -2.03% | 4.3分 |
| 94 | 易瑞生物 | -13.13% | -7.78% | 3.6分 |
| 96 | - | -13.31% | -6.28% | 分 |
| 98 | 基蛋生物 | -13.95% | -5.16% | 4.8分 |
| 100 | 赛诺医疗 | -14.01% | -6.31% | 4.6分 |
| 102 | 安杰思 | -14.32% | -8.20% | 4.5分 |
| 104 | 冠昊生物 | -14.43% | -4.74% | 4.2分 |
| 106 | 东星医疗 | -14.54% | 0.80% | 4.0分 |
| 108 | 康泰医学 | -14.75% | -4.40% | 3.5分 |
| 110 | - | -15.42% | -3.59% | 分 |
| 112 | 仁度生物 | -15.98% | -5.62% | 4.1分 |
| 114 | 爱威科技 | -17.08% | -8.23% | 4.2分 |
| 116 | 康拓医疗 | -17.75% | -8.89% | 4.6分 |
| 118 | 英诺特 | -18.30% | -7.16% | 4.6分 |
| 120 | 赛科希德 | -18.68% | -5.65% | 3.8分 |
| 122 | 奕瑞科技 | -19.42% | -7.10% | 5.9分 |
| 124 | 康为世纪 | -19.99% | -7.09% | 3.8分 |
| 126 | 安必平 | -20.89% | -8.39% | 3.7分 |
| 128 | 睿昂基因 | -21.36% | -9.67% | 3.6分 |
| 130 | 透景生命 | -23.12% | -10.01% | 3.8分 |
| 132 | 宝莱特 | -23.49% | -7.04% | 4.0分 |
| 134 | 热景生物 | -27.16% | -7.43% | 3.4分 |
| 136 | 华大智造 | -29.17% | -15.10% | 4.1分 |
| 138 | 爱迪特 | -30.33% | -19.53% | 4.6分 |
| 140 | 力诺药包 | -36.56% | -14.84% | 4.3分 |
| 142 | - | -48.11% | 22.68% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国都证券 | 2012-09-11 | 中性 | 增持 |
| 民族证券 | 2012-09-11 | 增持 | - |
| 长城证券 | 2012-09-10 | 中性 | 中性 |
| 民生证券 | 2012-09-10 | 中性 | 中性 |
| 东北证券 | 2012-09-10 | 中性 | 中性 |
更多>>行业资讯
- 2012-09-13ST联华重大诉讼进展情况
- 2012-09-13*ST黄海参加青岛辖区上市公司投资者网上集体接待日
- 2012-09-13骆驼股份签署募集资金专户存储四方监管协议
- 2012-09-13雷鸣科化中国证监会审核公司重大资产重组停牌
- 2012-09-13S仪化本公司股改进展的风险提示
- 2012-09-13亚星化学控股股东股权解除冻结
- 2012-09-13沃尔核材：向全资子公司香港沃尔贸易有限公司增资
- 2012-09-13超日太阳：子公司超日洛阳取得实用新型专利证书
- 2012-09-13神剑股份：对外提供财务资助
- 2012-09-13江南化工：公司申请发行短期融资券
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 74/243 ， 100/243。
[{"date":"2026-09-30","value":"2.15","vol":"4.03"},{"date":"2026-06-30","value":"1.34","vol":"2.35"},{"date":"2026-03-31","value":"0.01","vol":"1.12"},{"date":"2025-12-31","value":"-9.89","vol":"2.37"},{"date":"2025-09-30","value":"-3.56","vol":"3.06"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.15 | 1.34 | 0.01 | -9.89 | -3.56 |
| 行业(%) | 4.03 | 2.35 | 1.12 | 2.37 | 3.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"27.63","vol":"52.50"},{"date":"2026-06-30","value":"29.72","vol":"52.38"},{"date":"2026-03-31","value":"25.02","vol":"52.12"},{"date":"2025-12-31","value":"15.67","vol":"51.82"},{"date":"2025-09-30","value":"13.66","vol":"52.03"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
27.63 | 29.72 | 25.02 | 15.67 | 13.66 |
| 行业(%) | 52.50 | 52.38 | 52.12 | 51.82 | 52.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/243 ， 10/243。
[{"date":"2026-09-30","value":"28.88","vol":"7.76"},{"date":"2026-06-30","value":"29.67","vol":"5.46"},{"date":"2026-03-31","value":"6.33","vol":"5.59"},{"date":"2025-12-31","value":"-8.21","vol":"1.01"},{"date":"2025-09-30","value":"-10.15","vol":"0.11"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
28.88 | 29.67 | 6.33 | -8.21 | -10.15 |
| 行业(%) | 7.76 | 5.46 | 5.59 | 1.01 | 0.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"160.88","vol":"-81.68"},{"date":"2026-06-30","value":"179.72","vol":"-24.55"},{"date":"2026-03-31","value":"-98.84","vol":"-20.93"},{"date":"2025-12-31","value":"-70.32","vol":"-33.44"},{"date":"2025-09-30","value":"-30.09","vol":"-15.21"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
160.88 | 179.72 | -98.84 | -70.32 | -30.09 |
| 行业(%) | -81.68 | -24.55 | -20.93 | -33.44 | -15.21 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 29/243 ， 7/243。
[{"date":"2026-09-30","value":"0.35","vol":"0.27"},{"date":"2026-06-30","value":"0.23","vol":"0.17"},{"date":"2026-03-31","value":"0.10","vol":"0.08"},{"date":"2025-12-31","value":"0.34","vol":"0.35"},{"date":"2025-09-30","value":"0.25","vol":"0.25"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.35 | 0.23 | 0.10 | 0.34 | 0.25 |
| 行业(次) | 0.27 | 0.17 | 0.08 | 0.35 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"3.61","vol":"1.72"},{"date":"2026-06-30","value":"2.35","vol":"1.12"},{"date":"2026-03-31","value":"1.09","vol":"0.55"},{"date":"2025-12-31","value":"4.12","vol":"2.33"},{"date":"2025-09-30","value":"3.01","vol":"1.66"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.61 | 2.35 | 1.09 | 4.12 | 3.01 |
| 行业(次) | 1.72 | 1.12 | 0.55 | 2.33 | 1.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"15.65","vol":"13.36"},{"date":"2026-06-30","value":"16.74","vol":"14.81"},{"date":"2026-03-31","value":"4.45","vol":"-0.33"},{"date":"2025-12-31","value":"14.79","vol":"32.14"},{"date":"2025-09-30","value":"-7.70","vol":"14.86"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 15.65 | 16.74 | 4.45 | 14.79 | -7.70 |
| 行业 | 13.36 | 14.81 | -0.33 | 32.14 | 14.86 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.76","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.94","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.76 | - | 0.94 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.62 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 40/243 ， 21/243。
[{"date":"2026-09-30","value":"0.92","vol":"5.30"},{"date":"2026-06-30","value":"0.91","vol":"5.78"},{"date":"2026-03-31","value":"0.87","vol":"6.17"},{"date":"2025-12-31","value":"0.85","vol":"5.27"},{"date":"2025-09-30","value":"0.87","vol":"5.64"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.92 | 0.91 | 0.87 | 0.85 | 0.87 |
| 行业 | 5.30 | 5.78 | 6.17 | 5.27 | 5.64 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.61","vol":"4.25"},{"date":"2026-06-30","value":"0.62","vol":"4.71"},{"date":"2026-03-31","value":"0.62","vol":"5.04"},{"date":"2025-12-31","value":"0.59","vol":"4.13"},{"date":"2025-09-30","value":"0.58","vol":"4.49"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.61 | 0.62 | 0.62 | 0.59 | 0.58 |
| 行业 | 4.25 | 4.71 | 5.04 | 4.13 | 4.49 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 17/243 ， 12/243。
[{"date":"2026-09-30","value":"36.60","vol":"23.76"},{"date":"2026-06-30","value":"38.50","vol":"23.17"},{"date":"2026-03-31","value":"41.62","vol":"22.26"},{"date":"2025-12-31","value":"43.56","vol":"23.19"},{"date":"2025-09-30","value":"41.01","vol":"22.23"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
36.60 | 38.50 | 41.62 | 43.56 | 41.01 |
| 行业(%) | 23.76 | 23.17 | 22.26 | 23.19 | 22.23 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.73","vol":"0.39"},{"date":"2026-06-30","value":"0.84","vol":"0.42"},{"date":"2026-03-31","value":"0.95","vol":"0.40"},{"date":"2025-12-31","value":"1.02","vol":"0.41"},{"date":"2025-09-30","value":"0.85","vol":"0.72"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.73 | 0.84 | 0.95 | 1.02 | 0.85 |
| 行业(%) | 0.39 | 0.42 | 0.40 | 0.41 | 0.72 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"-3.72","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-5.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-4.46","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-7.59","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]